Renal transplantation in patients with classical haemolytic-uraemic syndrome
- PMID: 1911148
- DOI: 10.1007/BF00856651
Renal transplantation in patients with classical haemolytic-uraemic syndrome
Abstract
Eighteen records from children with renal transplants (RT) and classical haemolytic-uraemic syndrome (HUS) were reviewed. The mean oliguric period was 17.9 +/- 7.5 days; the interval between acute phase and end-stage renal disease (ESRD) was 9.3 +/- 5.2 years. HUS was the most frequent cause of renal transplantation (23.4%). There were no significant differences between patients with HUS and controls (children with RT but without HUS), regarding renal function, frequency of rejections, renal survival (HUS 65%, controls 57%) or patient survival (94.4% and 96.6%, respectively) after 9 years. None had clinical or histopathological evidence of HUS recurrence in the allograft. Of all children with living-related donors (LRD), renal survival after 3 years was longer for those who received cyclosporin A (CSA) (HUS and controls 86%) than for those who did not receive it (HUS 50%, controls 53%). Classical HUS is a frequent cause of ESRD in Argentina. The duration of the acute oliguric period is a good predictor of the likelihood of progression to chronicity. In the classical form of HUS there is no recurrence in the allograft. CSA and LRD can be used without risk in renal transplantation of children with classical HUS.
Similar articles
-
Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.Pediatr Nephrol. 2002 Oct;17(10):809-14. doi: 10.1007/s00467-002-0936-9. Epub 2002 Aug 10. Pediatr Nephrol. 2002. PMID: 12376808 Clinical Trial.
-
Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report.Nephrol Dial Transplant. 1997 Jul;12(7):1425-30. doi: 10.1093/ndt/12.7.1425. Nephrol Dial Transplant. 1997. PMID: 9249780
-
Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome.Nephrol Dial Transplant. 1996 Sep;11(9):1810-4. Nephrol Dial Transplant. 1996. PMID: 8918627
-
Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature.Nephron. 2017;136(3):245-253. doi: 10.1159/000468528. Epub 2017 Apr 19. Nephron. 2017. PMID: 28419995 Review.
-
Heterogeneity of atypical haemolytic uraemic syndromes.Arch Dis Child. 1997 Jun;76(6):518-21. doi: 10.1136/adc.76.6.518. Arch Dis Child. 1997. PMID: 9245850 Free PMC article. Review.
Cited by
-
Glomerular disease of transplanted kidneys.Clin Investig. 1993 Oct;71(10):840-2. doi: 10.1007/BF00190333. Clin Investig. 1993. PMID: 8305845 Review. No abstract available.
-
Non-immunological risk factors in paediatric renal transplantation.Pediatr Nephrol. 1993 Feb;7(1):89-95. doi: 10.1007/BF00861586. Pediatr Nephrol. 1993. PMID: 8439491 Review.
-
Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential.Clin Kidney J. 2017 Aug;10(4):490-493. doi: 10.1093/ckj/sfx030. Epub 2017 May 8. Clin Kidney J. 2017. PMID: 28852487 Free PMC article.
-
Cerebral infarct with recurrence of hemolytic-uremic syndrome in a child following renal transplantation.Pediatr Nephrol. 1992 Nov;6(6):550-2. doi: 10.1007/BF00866501. Pediatr Nephrol. 1992. PMID: 1482644
-
Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.Pediatr Nephrol. 2004 Oct;19(10):1148-52. doi: 10.1007/s00467-004-1516-y. Epub 2004 Jun 18. Pediatr Nephrol. 2004. PMID: 15221428
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical